Bethany Hospice And Palliative Care Of Coastal Ga in Claxton, Georgia

Bethany Hospice And Palliative Care Of Coastal Ga is a medicare-certified hospice facility in Claxton, Georgia. It is a for profit hospice and this hospice is a Freestanding Hospice. It is located at 8395 Us Highway 301 North in Claxton, Georgia. You can reach out to the office of Bethany Hospice And Palliative Care Of Coastal Ga via phone at (912) 739-0058.

Bethany Hospice And Palliative Care Of Coastal Ga is first approved in August, 2007 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 111658. Atlanta is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Bethany Hospice And Palliative Care Of Coastal Ga
8395 Us Highway 301 North, Claxton, GA, 30417
(912) 739-0058

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago

Map and Direction



Hospice Profile

NameBethany Hospice And Palliative Care Of Coastal Ga
Location8395 Us Highway 301 North, Claxton, Georgia
Hospice ID111658
CategoryFreestanding Hospice
Ownership TypeProprietary - Corporation
Profit TypeFOR PROFIT
SSA county code441

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Bethany Hospice And Palliative Care Of Coastal Ga from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1548501000
Organization NameBethany Hospice And Palliative Care Of Coastal Georgia, Llc
Address8395 Us Highway 301 Claxton, Georgia, 30417
Phone Number(912)739-0058

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago


Quality of Patient Care at Bethany Hospice And Palliative Care Of Coastal Ga

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Bethany Hospice And Palliative Care Of Coastal Ga has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care87.098.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care69.693.6
Patients who were checked for pain at the beginning of hospice care95.793.9
Patients who got a timely and thorough pain assessment when pain was identified as a problemNot Available77.7
Patients who were checked for shortness of breath at the beginning of hospice care95.797.3
Patients who got timely treatment for shortness of breathNot Available94.6
Patients taking opioid pain medication who were offered care for constipationNot Available93.3

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago


Services Provided by Bethany Hospice And Palliative Care Of Coastal Ga:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Bethany Hospice And Palliative Care Of Coastal Ga below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Nursing Service
    • Other Services

  • Under Arrangement
    • Medical Supply Service
    • Occupational Therapy
    • Physician Service
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Bethany Hospice And Palliative Care Of Coastal Ga
Home Health Aides2
Counselors1
Licensed Practical or Vocational Nurses1.5
Medical Social Workers 0.5
Physicians0.5
Registered Nurses6
Other Personnel2
Total Employees13.5

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago


Number of Full-time equivalent Volunteers:

Others8
Total Volunteers8

News Archive

Sen. Patrick Leahy to vote to end the health bill filibuster on Saturday

"Decision time is nearing on health insurance reform, and I will vote to end the filibuster on Saturday so the Senate can begin this important and historic debate. We cannot afford to let the health industry's sentries of the status quo kick the can down the road as they have done so often before. The country suffers when there is a failure to act on serious challenges that ordinary Americans face in their daily lives."

'Global brain connectivity' explains 10% of variance in individual intelligence

When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans? As science has long suspected, overall brain size matters somewhat, accounting for about 6.7 percent of individual variation in intelligence. More recent research has pinpointed the brain's lateral prefrontal cortex, a region just behind the temple, as a critical hub for high-level mental processing, with activity levels there predicting another 5 percent of variation in individual intelligence.

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

ITL Biomedical achieves significant sales of newly launched product, DonorCare Needle Guard 2

ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

Read more Medical News

› Verified 7 days ago

Ownership Details:

  • This hospice has undergone 1 time/s change of ownership.
  • Most recent change of ownership is on December, 2014.

Certification Details for Bethany Hospice And Palliative Care Of Coastal Ga:

  • February, 2017 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is eligible to participate in the medicare and/or medicaid program.
  • Blue Cross (south Carolina) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 31, December.

Hospices in Claxton

Bethany Hospice And Palliative Care Of Coastal Ga
Location: 8395 Us Highway 301 North, Claxton, Georgia, 30417
Phone: (912) 739-0058

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.